EVLO
Vanguard Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-357,711
| Closed | -$1.4M | – | 4593 |
|
2023
Q3 | $1.4M | Buy |
357,711
+201,815
| +129% | +$791K | ﹤0.01% | 3718 |
|
2023
Q2 | $507K | Sell |
155,896
-3,012,479
| -95% | -$9.79M | ﹤0.01% | 4118 |
|
2023
Q1 | $573K | Hold |
3,168,375
| – | – | ﹤0.01% | 4090 |
|
2022
Q4 | $5.1M | Sell |
3,168,375
-54,045
| -2% | -$87K | ﹤0.01% | 3298 |
|
2022
Q3 | $6.74M | Buy |
3,222,420
+1,862,098
| +137% | +$3.89M | ﹤0.01% | 3155 |
|
2022
Q2 | $2.87M | Sell |
1,360,322
-184,196
| -12% | -$389K | ﹤0.01% | 3646 |
|
2022
Q1 | $5.24M | Buy |
1,544,518
+132,702
| +9% | +$450K | ﹤0.01% | 3505 |
|
2021
Q4 | $8.57M | Sell |
1,411,816
-84,071
| -6% | -$510K | ﹤0.01% | 3307 |
|
2021
Q3 | $10.5M | Buy |
1,495,887
+19,103
| +1% | +$134K | ﹤0.01% | 3213 |
|
2021
Q2 | $20.3M | Buy |
1,476,784
+123,560
| +9% | +$1.7M | ﹤0.01% | 2836 |
|
2021
Q1 | $14.5M | Buy |
1,353,224
+199,158
| +17% | +$2.13M | ﹤0.01% | 2954 |
|
2020
Q4 | $14M | Buy |
1,154,066
+267,106
| +30% | +$3.23M | ﹤0.01% | 2821 |
|
2020
Q3 | $4.67M | Buy |
886,960
+13,906
| +2% | +$73.3K | ﹤0.01% | 3182 |
|
2020
Q2 | $4.28M | Buy |
873,054
+446,342
| +105% | +$2.19M | ﹤0.01% | 3171 |
|
2020
Q1 | $1.6M | Buy |
426,712
+944
| +0.2% | +$3.54K | ﹤0.01% | 3358 |
|
2019
Q4 | $1.73M | Sell |
425,768
-2,147
| -0.5% | -$8.72K | ﹤0.01% | 3490 |
|
2019
Q3 | $2.61M | Sell |
427,915
-7,420
| -2% | -$45.3K | ﹤0.01% | 3363 |
|
2019
Q2 | $3.91M | Buy |
435,335
+3,685
| +0.9% | +$33.1K | ﹤0.01% | 3253 |
|
2019
Q1 | $3.45M | Buy |
431,650
+117,781
| +38% | +$942K | ﹤0.01% | 3278 |
|
2018
Q4 | $4.08M | Buy |
313,869
+74,077
| +31% | +$964K | ﹤0.01% | 3156 |
|
2018
Q3 | $2.92M | Buy |
239,792
+172,804
| +258% | +$2.1M | ﹤0.01% | 3408 |
|
2018
Q2 | $790K | Buy |
+66,988
| New | +$790K | ﹤0.01% | 3745 |
|